Streetbeat News

Regulatory

APLT

IAUX

LUNR

Intuitive Machines (LUNR) shares surged 70% after securing a NASA contract worth up to $4.82 billion. Applied Therapeutics (APLT) shares rose 57% as the FDA waived the need for an advisory committee meeting. i-80 Gold (IAUX) shares increased 11% following the appointment of a new CEO.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 12:27 pm

QCOM

VGK

Qualcomm's appeal against a 2019 EU antitrust penalty was largely rejected by the European Union's General Court. The court upheld most of the 242 million euro fine for Qualcomm's alleged predatory pricing in the 3G baseband chipset market, slightly reducing it to 238.7 million euros. This decision follows a separate case where a $1.23 billion fine against Qualcomm was overturned.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 12:23 pm

PHGE

BiomX Inc. (NYSE:PHGE) will present data from its Phase 1b/2a clinical trial of BX004 for cystic fibrosis at the North American Cystic Fibrosis Conference. The study focuses on treating chronic Pseudomonas aeruginosa infections. Presentations will occur on September 27 and 28, 2024.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 12:19 pm

ELUT

Elutia Inc. has published preclinical data showing that its product, EluPro, effectively eradicates bacteria associated with cardiac implant infections. This antibiotic-eluting bio-envelope, cleared by the FDA, reduces bacterial colonization with minimal systemic antibiotic exposure.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 12:09 pm

IMMP

Immutep Limited will present new data from its Phase II trial, EFTISARC-NEO, at the CTOS 2024 Annual Meeting. The trial evaluates a novel triple combination therapy for soft tissue sarcoma, involving eftilagimod alpha, radiotherapy, and KEYTRUDA®.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 12:09 pm

MODD

Modular Medical has announced the issuance of a U.S. patent for key features of its core pumping technology in the FDA-cleared MODD1 insulin delivery product. This patent strengthens the company's intellectual property portfolio.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 12:08 pm

AVGR

Avinger has announced the issuance of a new U.S. patent and received notices of allowance for five additional patents, enhancing its intellectual property protection for intravascular image-guided systems and devices.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 12:07 pm

BCTX

BriaCell Therapeutics has received US FDA authorization for an Expanded Access Policy (EAP) to provide its treatment to metastatic breast cancer patients. This development could enhance the company's market presence and patient reach.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 11:51 am

SPAI

Safe Pro has received a Notice of Allowance from the US Patent and Trademark Office for its AI-powered Spotlightai drone image analysis and reporting software platform, which identifies, locates, and maps explosives.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 11:50 am

APLT

Applied Therapeutics shares rose after the FDA announced that an advisory committee meeting is no longer required for the company.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 11:42 am